What is the difference between pressure control ventilation (PCV) and volume control ventilation (VCV) in a patient with acute respiratory distress syndrome (ARDS)?

Pressure Control vs Volume Control Ventilation in ARDS

Direct Answer

For patients with ARDS, initiate mechanical ventilation using volume-controlled ventilation (VCV) in the early phase because it enables precise monitoring of plateau pressure and driving pressure—the key parameters that determine mortality—with no outcome advantage of pressure-controlled ventilation (PCV) over VCV when the same tidal volume is delivered. 1, 2

---

Rationale for Volume Control in Early ARDS

VCV is the preferred initial mode because it facilitates measurement of respiratory mechanics and driving pressure, which are critical for lung-protective ventilation. 1, 2 The ability to directly measure plateau pressure (≤30 cm H₂O) and calculate driving pressure (target ≤15 cm H₂O) is essential for preventing ventilator-induced lung injury through alveolar overdistension. 2

Key Ventilator Settings for VCV in ARDS:

• Tidal volume: 4-8 mL/kg predicted body weight (strong recommendation) 1, 2
• Plateau pressure: ≤30 cm H₂O (absolute ceiling, takes precedence over all other targets) 1, 2
• Driving pressure: ≤15 cm H₂O (better predictor of mortality than tidal volume or plateau pressure alone) 2
• PEEP: Higher levels for moderate-severe ARDS (PaO₂/FiO₂ ≤200 mmHg) 1, 2

---

When to Consider Pressure Control Ventilation

Transition to PCV may be appropriate later in the disease course during assisted breathing modes when patient comfort becomes a priority and sedation is being reduced. 1, 2 PCV may offer better respiratory comfort during assisted breathing because it does not limit inspiratory flow and can reduce work of breathing in patients with increased and variable respiratory demand. 3, 4

Specific Indications for Switching to PCV:

• Patient develops dyssynchrony during assisted modes 2
• Increased work of breathing despite adequate VCV settings 4
• Transition to weaning phase with partial ventilator support 2

---

Critical Caveats with Pressure Control

PCV does not guarantee a fixed tidal volume, which creates significant risk for inadvertent delivery of excessive volumes if lung compliance improves, or inadequate volumes if compliance worsens. 2 This requires vigilant monitoring of delivered tidal volumes to ensure they remain within the 4-8 mL/kg predicted body weight range. 2

Common Pitfalls to Avoid:

• Loss of tidal volume control: In 40% of patients, tidal volume markedly exceeded lung-protective targets during PCV in one study 5
• Variable minute ventilation: PCV results in variable tidal and minute volume that requires continuous adjustment 3
• Inability to measure plateau pressure directly: This makes it difficult to ensure the ≤30 cm H₂O target is maintained 1, 2

---

Evidence Quality Assessment

The recommendation for VCV over PCV is based on moderate-quality guideline evidence from the American Thoracic Society and European Society of Intensive Care Medicine 1, 2, supported by a Cochrane systematic review of 1,089 patients showing no mortality benefit with PCV (RR 0.83,95% CI 0.67-1.02 for in-hospital mortality). 6

Individual studies show conflicting results on work of breathing: One study demonstrated lower work of breathing with PCV (0.59 vs 0.70 J/L, p<0.05) 4, while another showed a nonsignificant trend toward higher work of breathing with PCV (1.27 J/L) compared to VCV (1.09 J/L). 5 These differences likely reflect variations in flow rate settings during VCV, as any benefit associated with PCV regarding work of breathing probably results from the decelerating-flow waveform, which is now available during VCV on most modern ventilators. 3

---

Algorithmic Approach

Phase 1: Initial Ventilation (First 24-72 hours)

1. Use VCV with the following settings: 1, 2

   • Tidal volume: 6 mL/kg PBW (may reduce to 4 mL/kg if plateau pressure >30 cm H₂O)
   • Plateau pressure: ≤30 cm H₂O (absolute priority)
   • Driving pressure: ≤15 cm H₂O
   • PEEP: Higher levels for moderate-severe ARDS
   • Inspiratory flow: 75 L/min or higher to meet patient demand 5

2. Monitor plateau pressure continuously to ensure lung-protective ventilation 2, 7

3. Accept permissive hypercapnia (pH ≥7.20) to maintain plateau pressure limits 2, 7

Phase 2: Assisted Breathing (After stabilization)

1. Consider switching to PCV if: 2

   • Patient develops ventilator dyssynchrony
   • Increased work of breathing despite optimized VCV
   • Sedation is being reduced and patient comfort is compromised

2. If using PCV, titrate inspiratory pressure to achieve: 2

   • Target tidal volume 4-8 mL/kg PBW
   • Monitor delivered volumes every 1-2 hours initially
   • Ensure plateau pressure remains ≤30 cm H₂O (may require periodic measurement)

Phase 3: Weaning

1. PCV may be preferred during weaning due to better patient-ventilator synchrony 2, 3

2. Continue monitoring tidal volumes vigilantly to prevent excessive volumes as compliance improves 2

---

Additional ARDS Management Considerations

Regardless of ventilation mode, implement these evidence-based interventions: 1, 2

• Prone positioning >12 hours/day if PaO₂/FiO₂ <150 mmHg (strong recommendation, reduces mortality) 1, 7
• Conservative fluid strategy for established ARDS without tissue hypoperfusion 2
• Neuromuscular blockade for ≤48 hours when PaO₂/FiO₂ <150 mmHg (weak recommendation) 2
• Avoid routine high-frequency oscillatory ventilation (strong recommendation against) 1